C

Concord Biotech Ltd
NSE:CONCORDBIO

Watchlist Manager
Concord Biotech Ltd
NSE:CONCORDBIO
Watchlist
Price: 2 019.3 INR 1.41% Market Closed
Market Cap: 211.3B INR
Have any thoughts about
Concord Biotech Ltd?
Write Note

EV/EBITDA
Enterprise Value to EBITDA

47.3
Current
35.4
Median
13.3
Industry
Higher than median
Higher than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
47.3
=
Enterprise Value
208.3B INR
/
EBITDA
4.4B INR
All Countries
Close

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
40.4
2-Years Forward
EV/EBITDA
31.1
3-Years Forward
EV/EBITDA
24.6

See Also

Discover More